Literature DB >> 8889319

Leishmaniasis. Public health aspects and control.

P Desjeux1.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8889319     DOI： 10.1016/0738-081x(96)00057-0

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN： 0738-081X            Impact factor:   3.541


× No keyword cloud information.
  152 in total

1.  Improvement of in vitro and in vivo antileishmanial activities of 2', 6'-dihydroxy-4'-methoxychalcone by entrapment in poly(D,L-lactide) nanoparticles.

Authors:  E C Torres-Santos; J M Rodrigues; D L Moreira; M A Kaplan; B Rossi-Bergmann
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

2.  Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal.

Authors:  Siddhivinayak Hirve; Shri Prakash Singh; Narendra Kumar; Megha Raj Banjara; Pradeep Das; Shyam Sundar; Suman Rijal; Anand Joshi; Axel Kroeger; Beena Varghese; Chandreshwar Prasad Thakur; M Mamun Huda; Dinesh Mondal
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

3.  Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model.

Authors:  M Paul; R Durand; H Fessi; D Rivollet; R Houin; A Astier; M Deniau
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

Review 4.  Insecticide resistance and its molecular basis in urban insect pests.

Authors:  Muhammad Nadir Naqqash; Ayhan Gökçe; Allah Bakhsh; Muhammad Salim
Journal:  Parasitol Res       Date:  2016-01-13       Impact factor: 2.289

5.  Diagnostic accuracy of two rK39 antigen-based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in northeastern Uganda.

Authors:  François Chappuis; Yolanda Mueller; Alexandre Nguimfack; John Bosco Rwakimari; Sophie Couffignal; Marleen Boelaert; Philippe Cavailler; Louis Loutan; Patrice Piola
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 6.  A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis.

Authors:  François Chappuis; Suman Rijal; Alonso Soto; Joris Menten; Marleen Boelaert
Journal:  BMJ       Date:  2006-08-01

7.  Visceral leishmaniasis prevalence and associated risk factors in the saran district of Bihar, India, from 2009 to July of 2011.

Authors:  Diana Perry; Kandice Dixon; Rajesh Garlapati; Alex Gendernalik; David Poché; Richard Poché
Journal:  Am J Trop Med Hyg       Date:  2013-02-04       Impact factor: 2.345

8.  Miltefosine (Impavido): the first oral treatment against leishmaniasis.

Authors:  H Sindermann; S L Croft; K R Engel; W Bommer; H J Eibl; C Unger; J Engel
Journal:  Med Microbiol Immunol       Date:  2003-09-26       Impact factor: 3.402

9.  Crystal structure of arginase from Leishmania mexicana and implications for the inhibition of polyamine biosynthesis in parasitic infections.

Authors:  Edward L D'Antonio; Buddy Ullman; Sigrid C Roberts; Upasna Gaur Dixit; Mary E Wilson; Yang Hai; David W Christianson
Journal:  Arch Biochem Biophys       Date:  2013-04-09       Impact factor: 4.013

10.  A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar.

Authors:  Bruno Bucheton; Laurent Abel; Sayda El-Safi; Musa M Kheir; Sylvana Pavek; Arnaud Lemainque; Alain J Dessein
Journal:  Am J Hum Genet       Date:  2003-10-13       Impact factor: 11.025
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.